Global Retinoblastoma Treatment Market 2015-2019 is the latest addition to ReportsnReports.com industry research reports collection.The report is about 62 pages and provides 26 Exhibits; the report is published in August-2015.
The analysts forecast global retinoblastoma market to grow at a CAGR of 3.57% over the period 2014-2019. Cancer occurs when normal cells transform to evade the regular cell cycle process. Retinoblastoma is a rare eye cancer. It occurs in children of age less than 15 years; the disease is common in children younger than five years, especially children less than two years. The disease affects the retina and is caused by a mutation in the gene RB1. It usually appears in one eye and gradually spreads to the other. Clinically, retinoblastoma is classified into two: unilateral retinoblastoma, tumor in one eye, and bilateral retinoblastoma, tumor in both the eyes.
Purchase a Copy of the Report @ http://www.reportsnreports.com/Purchase.aspx?name=410543 (Single User License - US $2500)
The report includes the present scenario and the growth prospects of the global retinoblastoma market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of retinoblastoma.
The report, Global Retinoblastoma Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as the market segmentation. The report includes a discussion of the key vendors operating in this market.
Key Regions: Americas, APAC, EMEA
Key Vendors: Baxter, Bristol-Myers Squibb, GlaxoSmithKline, Spectrum Pharmaceuticals
Other Prominent Vendors : BioLineRx, Cellceutix, Icon Bioscience, Neotropix, RXi Pharmaceuticals, Recombio
Market Driver - Increasing public awareness
Market Challenge - Treatment abandonment
Market Trend - Localized treatment approach
Inquire for this report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=410543
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Classification of Retinoblastoma
Exhibit 3: Symptoms: Percentage Occurrence in Patients
Exhibit 4: Techniques Used for Diagnosing Retinoblastoma
Exhibit 5: Intraocular Staging
Exhibit 6: Extraocular Staging
Exhibit 7: Retinoblastoma: Treatment Options
Exhibit 8: Global Retinoblastoma Market 2014-2019 (US$ million)
Exhibit 9: Pipeline Portfolio
Exhibit 10: Global Retinoblastoma Market by Therapeutic Class of Drugs
Exhibit 11: Global Retinoblastoma Market by Disease Status
Exhibit 12: Global Retinoblastoma Market: Percentage Share of Cases (2014)
Exhibit 13: Global Retinoblastoma Market by Geographical Segmentation 2014
Exhibit 14: Baxter
Exhibit 15: Bristol Myers-Squibb
Exhibit 16: GlaxoSmithKline
Exhibit 17: Spectrum Pharmaceuticals
Exhibit 18: Baxter International Inc. : Business Segmentation
Exhibit 19: Baxter International Inc.: Revenue by Business Segmentation 2013
Exhibit 20: Baxter International Inc.: Revenue by Geographical Segmentation 2013
Inquire for Discount on the Report at http://www.reportsnreports.com/contacts/Discount.aspx?name=410543 .
vBuy 3 reports at the coast of 2 (Lowest Priced Report will be free)
vBuy 4 and more reports and get 50% flat discount on the total Price
Contactsales@reportsandreports.com/ Call +1 888 391 5441 for further information on “Global Retinoblastoma Treatment Market 2015-2019” report OR for any other market research and intelligence needs you may have for your business.